About Delphinus Medical Technologies
Delphinus Medical Technologies is a company based in Plymouth (United States) founded in 2010 by Neb Duric. Delphinus Medical Technologies has raised $136.54 million across 14 funding rounds from investors including HHS, GE Capital and Trinity Cap. Delphinus Medical Technologies offers products and services including SoftVue. Delphinus Medical Technologies operates in a competitive market with competitors including CairnSurgical, Oncovision, Niramai, QT Imaging and Olive Healthcare, among others.
- Headquarter Plymouth, United States
- Founders Neb Duric
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Delphinus Medical Technologies
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$136.54 M (USD)
in 14 rounds
-
Latest Funding Round
$27.6 M (USD), Series D
Mar 22, 2024
-
Investors
HHS
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Delphinus Medical Technologies
Delphinus Medical Technologies offers a comprehensive portfolio of products and services, including SoftVue.
Offers 3D tomography for detecting breast cancer in dense tissues.
People of Delphinus Medical Technologies
Unlock access to complete
Funding Insights of Delphinus Medical Technologies
Delphinus Medical Technologies has successfully raised a total of $136.54M across 14 strategic funding rounds. The most recent funding activity was a Series D round of $27.6 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Delphinus Medical Technologies
Delphinus Medical Technologies has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, GE Capital and Trinity Cap.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt and equipment financing are provided to growth-stage companies.
|
Locked | Locked | Locked | |
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Locked | Locked | Locked | |
|
Investments are made in growth-stage startups by Beringea.
|
Locked | Locked | Locked |
Investor details for Delphinus Medical Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Delphinus Medical Technologies
Investment portfolio details for Delphinus Medical Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Delphinus Medical Technologies
Detailed financials for Delphinus Medical Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Delphinus Medical Technologies Comparisons
Peer comparison for Delphinus Medical Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Delphinus Medical Technologies
Delphinus Medical Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CairnSurgical, Oncovision, Niramai, QT Imaging and Olive Healthcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of 3D printed surgical guides for breast cancer treatment
|
|
| Locked | Locked | Locked |
Diagnostic imaging devices for oncology are manufactured and provided.
|
|
| Locked | Locked | Locked |
Early breast cancer is detected using AI-based non-invasive thermal imaging.
|
|
| Locked | Locked | Locked |
Non-invasive ultrasound device for breast cancer detection is developed.
|
|
| Locked | Locked | Locked |
Devices and software for wellness and medical uses are provided.
|
Detailed competitors of Delphinus Medical Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Delphinus Medical Technologies
Complete news archive for Delphinus Medical Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Delphinus Medical Technologies
Delphinus Medical Technologies was founded in 2010.
Delphinus Medical Technologies is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.
Scott A White is the current CEO of Delphinus Medical Technologies.
Delphinus Medical Technologies is a funded company, having raised a total of $136.54M across 14 funding rounds to date.
Delphinus Medical Technologies has designed and developed SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines womens breasts for the presence of benign andor malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. Sound and water are the basis of its technology, where acoustic signals resonating within breast tissue yield a unique signature that it measures. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Delphinus Medical Technologies's top competitors include QT Imaging, CairnSurgical and Niramai.
Delphinus Medical Technologies offers SoftVue.
Delphinus Medical Technologies has 11 investors. Key investors include HHS, GE Capital, Trinity Cap, Arboretum Ventures, and Beringea.